PAI
VRTX icon

Pittenger & Anderson Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Pittenger & Anderson Inc’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-939
Closed -$437K – 467
2024
Q3 		$437K Buy
939
+720
+329% +$346K 0.02% 189
2024
Q2 		$103K Buy
+219
New +$95.1K ﹤0.01% 267
2023
Q1 		– Sell
-325
Closed -$93.9K – 457
2022
Q4 		$93.9K Buy
+325
New +$99K 0.01% 244
2021
Q2 		– Sell
-93
Closed -$20K – 424
2021
Q1 		$20K Sell
93
-530
-85% -$116K ﹤0.01% 291
2020
Q4 		$147K Buy
623
+360
+137% +$82.6K 0.01% 210
2020
Q3 		$72K Buy
263
+27
+11% +$7.45K ﹤0.01% 235
2020
Q2 		$69K Hold
236
– – ﹤0.01% 229
2020
Q1 		$56K Buy
236
+20
+9% +$4.59K ﹤0.01% 232
2019
Q4 		$47K Buy
216
+25
+13% +$5.06K ﹤0.01% 275
2019
Q3 		$32K Hold
191
– – ﹤0.01% 283
2019
Q2 		$35K Hold
191
– – ﹤0.01% 277
2019
Q1 		$35K Buy
191
+75
+65% +$13.9K ﹤0.01% 284
2018
Q4 		$19K Buy
116
+4
+4% +$693 ﹤0.01% 288
2018
Q3 		$22K Buy
112
+7
+7% +$1.25K ﹤0.01% 297
2018
Q2 		$18K Hold
105
– – ﹤0.01% 306
2018
Q1 		$17K Buy
+105
New +$17.2K ﹤0.01% 308
2016
Q1 		– Sell
-50
Closed -$6K – 418
2015
Q4 		$6K Hold
50
– – ﹤0.01% 380
2015
Q3 		$5K Hold
50
– – ﹤0.01% 414
2015
Q2 		$6K Buy
50
+25
+100% +$3.15K ﹤0.01% 395
2015
Q1 		$3K Hold
25
– – ﹤0.01% 406
2014
Q4 		$3K Buy
+25
New +$2.82K ﹤0.01% 406

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Pittenger & Anderson Inc's VRTX Position: Q4 2024 in Review

Pittenger & Anderson Inc sold out of Vertex Pharmaceuticals (VRTX) in Q4 2024, closing a stake of 939 shares — an estimated $437K sold.

Pittenger & Anderson Inc first reported a position in VRTX in Q4 2014 and held it in 21 quarters. The position peaked at $437K in Q3 2024. 1,557 funds tracked by Wall St. Rank hold VRTX as of Q4 2024.

  • Pittenger & Anderson Inc reported no remaining Vertex Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Pittenger & Anderson Inc sold 939 Vertex Pharmaceuticals shares in Q4 2024, an estimated $437K.
  • Pittenger & Anderson Inc first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 21 quarters.
  • Pittenger & Anderson Inc's Vertex Pharmaceuticals position peaked at $437K in Q3 2024.
  • 1,557 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2024.

Based on Pittenger & Anderson Inc's 13F filing for Q4 2024, filed 31 Jan 2025.